Hayek Kallen Investment Management purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 24,059 shares of the company’s stock, valued at approximately $3,092,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. ADAR1 Capital Management LLC bought a new stake in Merck KGaA in the second quarter worth about $403,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in Merck KGaA in the second quarter valued at approximately $942,087,000. Whalen Wealth Management Inc. purchased a new position in Merck KGaA in the second quarter valued at approximately $1,600,000. Cibc World Market Inc. purchased a new stake in Merck KGaA in the second quarter worth $186,005,000. Finally, Madison Wealth Partners Inc purchased a new stake in Merck KGaA in the second quarter worth $1,031,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Trading Down 3.9%
Shares of Merck KGaA stock opened at $158.15 on Friday. The stock has a market capitalization of $20.44 billion, a P/E ratio of 24.14 and a beta of 0.96. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The stock’s 50-day simple moving average is $163.21 and its 200 day simple moving average is $148.95.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
